Abstract
Transgene expression for the mammary gland bioreactor aimed at producing recombinant proteins requires optimized expression vector construction. Previously we presented a hybrid gene locus strategy, which was originally tested with human lactoferrin (hLF) as target transgene, and an extremely high-level expression of rhLF ever been achieved as to 29.8 g/l in mice milk. Here to demonstrate the broad application of this strategy, another 38.4 kb mWAP-htPA hybrid gene locus was constructed, in which the 3-kb genomic coding sequence in the 24-kb mouse whey acidic protein (mWAP) gene locus was substituted by the 17.4-kb genomic coding sequence of human tissue plasminogen activator (htPA), exactly from the start codon to the end codon. Corresponding five transgenic mice lines were generated and the highest expression level of rhtPA in the milk attained as to 3.3 g/l. Our strategy will provide a universal way for the large-scale production of pharmaceutical proteins in the mammary gland of transgenic animals.
Similar content being viewed by others
References
Shi, G., Chen, H., Wu, X., Zhou, Y., Liu, Z., Zheng, T., et al. (2009). A mWAP-hLF hybrid gene locus gave extremely high level expression of human lactoferrin in the milk of transgenic mice. Transgenic Research, 18(4), 573–582.
Nagasawa, T., Kiyosawa, L., & Takase, M. (1974). Lactoferrin and serum albumin of human casein in colostrum and milk. Journal of Dairy Science, 57(10), 1159–1163.
Liang, B. A., Lew, R., & Zivin, J. A. (2008). Review of tissue plasminogen activator, ischemic stroke, and potential legal issues. Archives of Neurology, 65(11), 1429–1433.
MacGregor, I. R., & Prowse, C. V. (1983). Tissue plasminogen activator in human plasma measured by radioimmunoassay. Thrombosis Research, 31(3), 461–474.
Datsenko, K. A., & Wanner, B. L. (2000). One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proceedings of the National Academy of Sciences of the United States of America, 97, 6640–6645.
Chandler, K. J., Chandler, R. L., Broeckelmann, E. M., Hou, Y., Southard-Smith, E. M., & Mortlock, D. P. (2007). Relevance of BAC transgene copy number in mice: Transgene copy number variation across multiple transgenic lines and correlations with transgene integrity and expression. Mammalian Genome, 18, 693–708.
Collen, D., Topol, E. J., Tiefenbrunn, A. J., Gold, H. K., Weisfeldt, M. L., Sobel, B. E., et al. (1984). Coronary thrombolysis with recombinant human tissue-type plasminogen activator: A prospective, randomized, placebo-controlled trial. Circulation, 70, 1012–1017.
Braunwald, E. (1988). Thrombolytic reperfusion of acute myocardial infarction: Resolved and unresolved issues. Journal of the American College of Cardiology, 12, 85A–92A.
Pittus, C. W., Hennighausen, L., Lee, E., Westphal, H., Nicols, E., Vitale, J., et al. (1988). A milk protein gene promoter directs the expression of human tissue plasminogen activator cDNA to the mammary gland in transgenic mice. Proceedings of the National Academy of Sciences of the United States of America, 85(16), 5874–5878.
Sha, H. Y., Liu, S. G., Chen, J. Q., Zhang, A. M., & Cheng, G. X. (2006). Expression of a variant of human tissue-type plasminogen activator in transgenic mouse milk. Journal of Experimental Animal Science, 43, 211–218.
Riego, E., Limonta, J., Aguilar, A., Pérezl, R., de Armas, R., Solano, R., et al. (1993). Production of transgenic mice and rabbits that carry and express the human tissue plasmonogen activator cDNA under the control of alpha s1 casein promoter. Theriogenology, 39(5), 1173–1185.
Ebert, K. M., Selgrath, J. P., Di Tullio, P., Denman, J., Smith, T. E., Memon, M. A., et al. (1991). Transgenic production of a variant of human tissue-type plasminogen activator in goat milk: Generation of transgenic goats and analysis of expression. Nature Biotechnology, 9(9), 835–838.
Ebert, K. M., Di Tullio, P., Barry, C. A., Schindler, J. E., Ayres, S. L., Smith, T. E., et al. (1994). Induction of human tissue plasminogen activator in the mammary gland of transgenic goats. Nature Biotechnology, 12(7), 699–702.
Chrenek, P., Makarevich, A. V., Pivko, J., Massanyi, P., & Lukac, N. (2007). Expression of recombinant human factor VIII in milk of several generations of transgenic rabbits. Transgenic Research, 16(3), 353–361.
Gunzburg, W. H., Salmons, B., Zimmermann, B., Muller, M., Erfle, V., & Brem, G. (1991). A mammary-specific promoter directs expression of growth hormone not only to the mammary gland, but also to Bergman glia cells in transgenic mice. Molecular Endocrinology, 5(1), 123–133.
Wen, J., Kawamata, Y., Tojo, H., Tanaka, S., & Tachi, C. (1995). Expression of whey acidic protein (WAP) genes in the tissues other than the mammary gland in normal and transgenic mice expressing mWAP/hGH fusion gene. Molecular Reproduction and Development, 41(4), 399–406.
Wagner, K. U., Wall, R. J., St-Ongel, L., Gruss, P., Wynshaw-Boris, A., Garrett, L., et al. (1997). Cre-mediated gene deletion in the mammary gland. Nucleic Acids Research, 25(21), 4323–4330.
Saidi, S., Rival-Gervier, S., Daniel-Carlier, N., Thepot, D., Morgenthaler, C., Viglietta, C., et al. (2007). Distal control of the pig whey acidic protein (WAP) locus in transgenic mice. Gene, 401(1–2), 97–107.
Devinoy, E., Montoliu, L., Baranyi, M., Thepot, D., Hiripi, L., Fontaine, M. L., et al. (2005). Analysis of the efficiency of the rabbit whey acidic protein gene 5′ flanking region in controlling the expression of homologous and heterologous linked genes. Journal of Dairy Research, 72(spec), 113–119.
Acknowledgments
This research was supported by the fund 2009ZX10004-402 from National Major Science and Technology Program for Infectious Disease.
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors Yanrong Zhou, Yanli Lin, and Xiaojie Wu contributed equally to this work.
Rights and permissions
About this article
Cite this article
Zhou, Y., Lin, Y., Wu, X. et al. The High-Level Expression of Human Tissue Plasminogen Activator in the Milk of Transgenic Mice with Hybrid Gene Locus Strategy. Mol Biotechnol 50, 137–144 (2012). https://doi.org/10.1007/s12033-011-9428-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12033-011-9428-0